Table 4.
Follow-up delta-values (anthropometrics and biomarkers) for the participants included in the follow-up analysis.
| Group X | Group Y | P-value | |
|---|---|---|---|
| N | 51 (60%) | 34 (40%) | |
| BMI-SDS, kg/m2 | −0.6 (0.5) | 0.0 (0.3) | <0.01 |
| DEXA-FM, % | −5.7 (4.9) | 3.0 (2.1) | <0.01 |
| Cholesterol, mmol/L | −0.1 (0.5) | 0.0 (0.6) | 0.26 |
| HDL, mmol/L | 0.1 (0.2) | −0.2 (0.2) | <0.01 |
| LDL, mmol/L | −0.2 (0.5) | 0.0 (0.5) | 0.04 |
| Triglycerides, mmol/L | −0.2 (0.4) | 0.3 (0.6) | <0.01 |
| LDH, mmol/L | −22.0 (35.8) | −7.3 (26.7) | 0.04 |
| ALAT, IU/L | −0.8 (8.6) | 3.1 (24.3) | 0.38 |
| Bilirubin, μmol/L | 1.9 (3.5) | 1.6 (2.) | 0.59 |
| Fasting glucose, mmol/L | 0.0 (0.4) | 0.0 (0.4) | 0.99 |
| HbA1c, mmol/L | −0.2 (0.4) | 0.0 (0.4) | 0.02 |
| TSH, 10−3 IU/L | −0.1 (1.1) | −0.3 (0.9) | 0.18 |
| T3, pmol/L | −0.3 (0.8) | −0.1 (0.7) | 0.3 |
| Albumin, g/L | −0.5 (2.6) | 0.3 (2.6) | 0.19 |
| Creatinine, μmol/L | 4.2 (5.9) | 2.7 (5.1) | 0.22 |
| Carbamide, mmol/L | 0.4 (1.4) | 0.3 (1.1) | 0.56 |
| Uric acid, mmol/L | −0.01 (0.05) | 0.01 (0.03) | 0.01 |
Group X consists of the children who reduced DEXA-FM and Group Y consists of the children who increased DEXA-FM. p-values represent differences between group X and Y. All data are reported as mean value with standard deviations (SD).